Basel / Kaiseraugst

Roche is committed to Switzerland and our Basel/Kaiseraugst site in the long term. In order to remain competitive, we must continue to develop. Our strategic site development adapts flexibly and continuously to Roche's local and global business developments. In this way we strengthen our appeal and competitiveness, which are essential for sustainable corporate success.

Roche will invest CHF 1.2 billion in another research and development building, the renewal of the synthetic chemical molecule production and a building for the Institute of Human Biology. The new buildings will expand the infrastructure for future innovations along the entire pharmaceutical value chain, from research to production.

Sustainability is the focus of all construction projects. We use high-quality, durable materials, reduce the energy consumption, employ regenerative energy and support biodiversity.

Our site in change

Discover more

Explore Building 1 and Building 2 virtually

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout Roche SwitzerlandOur pharmaceuticalsRoche DiagnosticsRoche careersMediaPrivacy PolicyLegal Statement